Narges Bazargani, PhD, CEO

Based in London, Narges is a neuroscience PhD graduate from University College London (UCL), who has experience in drug development at both start-up and large long-established pharmaceutical companies.
Narges has broad-ranging expertise in neuroscience, and is excited by facilitating the development of treatments for conditions that affect the central nervous system (CNS).
Greg Bryant, Head of Partnerships

Based in New York City, Greg has spent over 10 years working with Clinical Development teams at Biotech & CRO’s, focusing on CNS & optimizing drug development programs. Most recently he ran the strategic partnerships for a cognitive health app focusing on lifestyle interventions for Alzheimer’s & memory loss patients. 
Greg is passionate about finding new treatments for neurodegenerative diseases.